Researchers at Lehigh University in the US have relied on an anticancer therapeutic approach to create a new drug that will kill bacteria that are resistant to antibiotics. This drug will be used to treat patients with pneumonia, people with food poisoning, and patients who even the new generation of antibiotics do not seem to help them overcome the problem they face.
The researchers studied a new promising antitumour immunotherapy that activates the immune system to locate and attack cancerous tumors. They then created a drug that acts in a similar way against bacteria. More specifically, this drug activates the immune system to detect bacteria and attack them by destroying the outer surface of their cells, which leads them to death soon.
Researchers have experimented with this drug against bacteria that are listed on the World Health Organization’s list as bacteria with particularly high antibiotic resistance. Among them is the bacterium
Pseudomonas aeruginosa, which causes pneumonia in cancer patients, in burns and in patients with cystic fibrosis. The experiments that made the new drug killed this bacterium. The scientific community has welcomed this research effort that creates optimism that new effective drugs may soon be put in the fight against resistant bacteria.